Viewing Study NCT01902251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-06-26 @ 4:10 AM
Study NCT ID: NCT01902251
Status: COMPLETED
Last Update Posted: 2014-09-09
First Post: 2013-07-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Pharmacokinetics of Enzalutamide View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None Prostate cancer View
None Bioavailability View
None Food effect View
None Pharmacokinetics View
None Xtandi View
None Enzalutamide View
None MDV3100 View